Advanced search×

Engineering the future with cell biology.

Mol Biol Cell 21(22):3822 (2010) PMID 21079030

DOI: 10.1091/mbc.E10-04-0344
Version: za2963e q8za0 q8zb8 q8zc7 q8zd9 q8ze6 q8zfe q8zg9

Similar articles you may find interesting…

  1. [Allergen immunotherapy for allergic rhinitis.]

    Rhinology 51(2):99-110 (2013) PMID 23671890

    Allergic rhinitis, a risk factor for bronchial asthma, is a global health problem that impairs patients` physical and social activity and consequently their quality of life. Specific Immunotherapy (SIT) involves the administration, subcutaneously or sublin- gually, of increasing dose...
  2. Botulinum neurotoxin G binds synaptotagmin-II in a mode similar to serotype B: tyrosine-1186 and lysine-1191 cause its lower affinity.

    Biochemistry (2013) PMID 23647335

    We systematically mutated the synaptotagmin binding site in BoNT/G and performed a comparative binding analysis with mutants of the cell binding subunit of BoNT/B. The results suggest that synaptotagmin takes the same overall orientation in BoNT/B and BoNT/G governed by the strictly conserved centra...
  3. In vitro biological and mechanical evaluation of various scaffold materials for myocardial tissue engineering.

    J Biomed Mater Res A (2013) PMID 23650018

    We compared polyurethane, Collagen Cell Carriers, ePTFE and ePTFE SSP1-RGD regarding their receptiveness to seeding with mesenchymal stem cells isolated from umbilical cord tissue. Seeding was tested at an array of cell seeding densities. The bioartificial patches were cultured for up to 35 days and...